Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have received an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $79.67.
A number of equities analysts have recently commented on ACHC shares. KeyCorp assumed coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada cut their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th.
View Our Latest Research Report on Acadia Healthcare
Hedge Funds Weigh In On Acadia Healthcare
Acadia Healthcare Trading Down 1.6 %
Shares of ACHC stock opened at $40.63 on Monday. The firm’s 50-day simple moving average is $50.46 and its 200-day simple moving average is $63.52. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77. The firm has a market cap of $3.77 billion, a P/E ratio of 13.32, a PEG ratio of 1.80 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the business earned $0.91 EPS. As a group, equities analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Retail Stocks Investing, Explained
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is the Australian Securities Exchange (ASX)
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.